Targeting mixed lineage kinases in ER-positive breast cancer cells leads to G2/M cell cycle arrest and apoptosis

Estrogen receptor (ER)-positive tumors represent the most common type of breast cancer, and ER-targeted therapies such as antiestrogens and aromatase inhibitors have therefore been widely used in breast cancer treatment. While many patients have benefited from these therapies, both innate and acquir...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Limin, Gallo, Kathleen A., Conrad, Susan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787148/
https://www.ncbi.nlm.nih.gov/pubmed/23902710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787148/
https://www.ncbi.nlm.nih.gov/pubmed/23902710

Ejemplares similares